Cost of increasing access to artemisinin combination therapy: the Cambodian experience

BACKGROUND: Malaria-endemic countries are switching antimalarial drug policy from cheap ineffective monotherapies to artemisinin combination therapies (ACTs) for the treatment of Plasmodium falciparum malaria and the global community are considering setting up a global subsidy to fund their purchase...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeung, Shunmay, Van Damme, Wim, Socheat, Duong, White, Nicholas J, Mills, Anne
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2413253/
https://www.ncbi.nlm.nih.gov/pubmed/18492245
http://dx.doi.org/10.1186/1475-2875-7-84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2413253/
https://www.ncbi.nlm.nih.gov/pubmed/18492245
http://dx.doi.org/10.1186/1475-2875-7-84

Ejemplares similares